Pharmaceuticals - Scottsdale, AZ, United States
ImmuneRegen BioSciences is engaged in the research and development of the drug candidate, Homspera® for use as an immunomodulatory agent and stimulator of human adult stem cells. The company is focused on developing therapeutics aimed at specific disease targets including influenza, cancers (solid and blood), pulmonary fibrosis and neutropenia. Other areas of research for potential applications include stimulation of stem cells and wound healing. The company is also pursuing Homspera for use as a possible countermeasure for homeland security threats including radiation exposure, and chemical and biological agents.
Amazon AWS